In our prostate cancer world, getting 2nd opinions is critical. It’s easy to find a medical second opinion, and you can have your pathology reread by the best. But MRIs – that’s been challenging.
Now there’s an affordable AI-validated option that’s proven very reliable* – ProstatID
Founder and Developer, Randall Jones, PhD, explains the technology and its uses. Hosted by AnCan Advisory Board Member and prostate cancer peer, Cdr. Mike Crosby
*Sensitivity and Specificity in the mid-90% range
Click here to view the slides.
AnCan thanks the following sponsors for making this recording possible: Bayer, Novartis, Johnson and Johnson, Myriad Genetics, Telix, Blue Earth Diagnostics, and Foundation Medicine. Views expressed in this Recording are solely the opinion of AnCan Foundation, our Moderators, and Participants.
AnCan does not accept sponsored promotions. Any drugs, protocols, or devices discussed are based solely on anecdotal peer experience or clinical evidence. AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so, call 1-800-332-1066 or downloadthe interactive FDA Form 3500 https://www.fda.gov/media/76299/download
To SIGN UP for any of our Virtual Support groups, visit our Contact Us page.